Home › Trial NCT00102219
A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer
- Trial IDNCT00102219
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorEli Lilly and Company
- Enrollment77
- Start date2004-10
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.